Abstract
Background: Fructose has been widely used for producing lower post-infusion glucose increase than other carbohydrates, but it seems that it promotes an increase in post-infusion triglycerides.
Objective: The present study investigated the effects of fructose and glucose in metabolic variables and appetite sensations in patients with type 1 diabetes mellitus (T1DM).
Methods: This is a single-blind, randomized, and crossover study (washout of 1-5 weeks), which evaluated 16 adult T1DM patients, accompanied at University Hospital. After eight hours of overnight fasting, there was an assessment of capillary blood glucose, anthropometric variables, appetite sensations, and laboratory tests (glycemia, lipemia, leptin and glucagon) were conducted. Subsequently, they received 200mL of solutions with water and 75g of crystal fructose or glucose. Appetite sensations and capillary blood glucose were evaluated in different post-infusion times. Blood was drawn after 180 minutes for the laboratory tests.
Results: Blood glucose increased after the intake of both solutions, but glucose induced a higher elevation. None of them increased triglycerides or glucagon. Glucagon maintenance was similar among the solutions. Furthermore, both solutions reduced leptin and increased fullness, but only fructose increased the lack of interest in eating sweets.
Conclusion: Fructose induced a smaller increase in postprandial blood glucose than glucose, without changes in triglycerides and glucagon. In addition, leptin levels and appetite sensations were similar to glucose. Other studies are needed in order to confirm these findings, especially in the long term, so that their use becomes really reliable.
Keywords: Type 1 diabetes mellitus, carbohydrates intake, glycemia, lipid profile, hormones, appetite.
[1]
Brasileira de Diabetes S. Diretrizes 2017-2018. São Paulo, SP: AC Farmacêutica Ltda 2017.https://www.diabetes.org.br/
[2]
Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr 2009; 139(6): 1263S-8S.
[PMID: 19403723]
[PMID: 19403723]
[3]
Hollenbeck CB. Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. Am J Clin Nutr 1993; 58(Suppl. 5): 800S-9S.
[PMID: 8213613]
[PMID: 8213613]
[4]
Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005; 63(5): 133-57.
[PMID: 15971409]
[PMID: 15971409]
[5]
Chong MFF, Fielding BA, Frayn KN. Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr 2007; 85(6): 1511-20.
[PMID: 17556686]
[PMID: 17556686]
[6]
Couch SC, Crandell JL, Shah AS, et al. Fructose intake and cardiovascular risk factors in youth with type 1 diabetes: SEARCH for diabetes in youth study. Diabetes Res Clin Pract 2013; 100(2): 265-71.
[PMID: 23540682]
[PMID: 23540682]
[7]
Äkerblom HK, Siltanen I, Kallio AK. Does dietary fructose affect the control of diabetes in children? Acta Med Scand Suppl 1972; 542: 195-202.
[PMID: 4516490]
[PMID: 4516490]
[8]
Pelkonen R, Aro A, Nikkilä EA. Metabolic effects of dietary fructose in insulin dependent diabetes of adults. Acta Med Scand Suppl 1972; 542: 187-93.
[PMID: 4579750]
[PMID: 4579750]
[9]
Bantle JP, Laine DC, Thomas JW. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA 1986; 256(23): 3241-6.
[PMID: 3783868]
[PMID: 3783868]
[10]
Paganus A, Mäenpää J, Akerblom HK, Stenman UH, Knip M, Simell O. Beneficial effects of palatable guar and guar plus fructose diets in diabetic children. Acta Paediatr Scand 1987; 76(1): 76-81.
[PMID: 3551494]
[PMID: 3551494]
[11]
Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992; 15(11): 1468-76.
[PMID: 1468273]
[PMID: 1468273]
[12]
Rezvani R, Cianflone K, McGahan JP, et al. Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: Relationships with metabolic outcomes. Obesity (Silver Spring) 2013; 21(12): 2471-80.
[PMID: 23512943]
[PMID: 23512943]
[13]
Lee YC, Ko YH, Hsu YP, Ho LT. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Life Sci 2006; 78(11): 1155-62.
[PMID: 16436285]
[PMID: 16436285]
[14]
Melanson KJ, Zukley L, Lowndes J, Nguyen V, Angelopoulos TJ, Rippe JM. Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition 2007; 23(2): 103-12.
[PMID: 17234503]
[PMID: 17234503]
[15]
Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H. Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 2002; 51(4): 893-900.
[PMID: 11916904]
[PMID: 11916904]
[16]
Kramer CK, Borgoño CA, Van Nostrand P, Retnakaran R, Zinman B. Glucagon response to oral glucose challenge in type 1 diabetes: Lack of impact of euglycemia. Diabetes Care 2014; 37(4): 1076-82.
[PMID: 24241790]
[PMID: 24241790]
[17]
Moore MC, Davis SN, Mann SL, Cherrington AD. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 2001; 24(11): 1882-7.
[PMID: 11679451]
[PMID: 11679451]
[18]
Paquot N, Schneiter P, Jéquier E, et al. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects. Diabetologia 1996; 39(5): 580-6.
[PMID: 8739918]
[PMID: 8739918]
[19]
Arafat AM, Weickert MO, Adamidou A, et al. The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus. J Clin Endocrinol Metab 2013; 98(10): 4133-42.
[PMID: 23966238]
[PMID: 23966238]
[20]
Rodin J. Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake. Am J Clin Nutr 1990; 51(3): 428-35.
[PMID: 2178391]
[PMID: 2178391]
[22]
Rodacki M, Milech A, Oliveira JEP. A secreção residual do peptídeo C faz diferença no tratamento do diabetes melito tipo 1? Arq Bras Endocrinol Metabol 2008; 52(2): 322-33.
[PMID: 18438543]
[PMID: 18438543]
[23]
Greenbaum CJ, Harrison LC. Immunology of diabetes society guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes. Diabetes 2003; 52(5): 1059-65.
[PMID: 12716733]
[PMID: 12716733]
[24]
National Cholesterol Education Program - Adult Treatment Panel III National Institutes of Health (National Heart, Lung, and Blood Institute) 2002. http://www.nhlbi.nih.gov/guidelines/cholesterol/ atp3full.pdf
[25]
American Diabetes Association. Standards of medical care in diabetes - 2019. Diabetes Care 2019; 42(Suppl. 1): S113-23.
[26]
Milhoransa P, Soares R. Hormônio de estimulação da tireóide (TSH) e correlações laboratoriais. RBAC 2009; 41(2): 161-4.
[27]
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139(2): 137-47.
[PMID: 12859163]
[PMID: 12859163]
[28]
Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46(12): 2050-68.
[PMID: 11106350]
[PMID: 11106350]
[29]
Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24(1): 38-48.
[PMID: 10702749]
[PMID: 10702749]
[30]
Crapo PA, Scarlett JA, Kolterman OG. Comparison of the metabolic responses to fructose and sucrose sweetened foods. Am J Clin Nutr 1982; 36(2): 256-61.
[PMID: 7048890]
[PMID: 7048890]
[31]
Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57(6): e1-e47.
[PMID: 21617152]
[PMID: 21617152]
[32]
Fontanive RS, De Paula TP, Peres WAF. Inquéritos dietéticos.Semiologia nutricional. (Ed.; Axcel Books: Rio de Janeiro.). Duarte, A.C.: Castellani, F.R 2002; pp. 59-78.
[34]
Matsudo S, Araújo T, Matsudo V, et al. Questionário internacional de atividade física (IPAQ): estudo de validade e reprodutibilidade no Brasil. RBAFS 2001; 6(2): 5-18.
[35]
Brasil. Ministério da Saúde.. Sistema de Vigilância Alimentar e Nutricional Orientações para a coleta e análise de dados antropométricos em serviços de saúde 2008.
[36]
World Health Organization. Physical status: The use and interpretation of anthropometry WHO-Technical Report Series, 854 1995; 47. http://whqlibdoc.who.int/trs/WHO_TRS_854.pdf
[37]
Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41(4): 810-7.
[PMID: 3984933]
[PMID: 3984933]
[38]
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual (Abridged Edition.). 1991; 90.
[39]
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502.
[PMID: 4337382]
[PMID: 4337382]
[40]
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31-41.
[PMID: 1244564]
[PMID: 1244564]
[41]
Iida T, Kishimoto Y, Yoshikawa Y, et al. Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. J Nutr Sci Vitaminol (Tokyo) 2008; 54(6): 511-4.
[PMID: 19155592]
[PMID: 19155592]
[42]
Colhoun HM, Rubens MB, Underwood SR, Fuller JH. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol 2000; 36(7): 2160-7.
[PMID: 11127456]
[PMID: 11127456]
[43]
Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC. Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 1983; 309(1): 7-12.
[PMID: 6343873]
[PMID: 6343873]
[44]
Swarbrick MM, Stanhope KL, Elliott SS, et al. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 2008; 100(5): 947-52.
[PMID: 18384705]
[PMID: 18384705]
[45]
Lê KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89(6): 1760-5.
[PMID: 19403641]
[PMID: 19403641]
[46]
Stanhope KL, Griffen SC, Bremer AA, et al. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am J Clin Nutr 2011; 94(1): 112-9.
[PMID: 21613559]
[PMID: 21613559]
[47]
Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119(5): 1322-34.
[PMID: 19381015]
[PMID: 19381015]
[48]
Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88(5): 1419-37.
[PMID: 18996880]
[PMID: 18996880]
[49]
Lê KA, Faeh D, Stettler R, et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 2006; 84(6): 1374-9.
[PMID: 17158419]
[PMID: 17158419]
[50]
Aeberli I, Gerber PA, Hochuli M, et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011; 94(2): 479-85.
[PMID: 21677052]
[PMID: 21677052]
[51]
Matikainen N, Söderlund S, Björnson E, et al. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men. Nutr Metab Cardiovasc Dis 2017; 27(6): 534-42.
[PMID: 28428027]
[PMID: 28428027]
[52]
Johnston RD, Stephenson MC, Crossland H, et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013; 145(5): 1016-25.
[PMID: 23872500]
[PMID: 23872500]
[53]
Dolan LC, Potter SM, Burdock GA. Evidence-based review on the effect of normal dietary consumption of fructose on blood lipids and body weight of overweight and obese individuals. Crit Rev Food Sci Nutr 2010; 50(10): 889-918.
[PMID: 21108071]
[PMID: 21108071]
[54]
Lindqvist A, Baelemans A, Erlanson-Albertsson C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept 2008; 150(1-3): 26-32.
[PMID: 18627777]
[PMID: 18627777]
[55]
Rodrigues DF, Henriques MCC, Oliveira MC, et al. Acute intake of a high-fructose diet alters the balance of adipokine concentrations and induces neutrophil influx in the liver. J Nutr Biochem 2014; 25(4): 388-94.
[PMID: 24485988]
[PMID: 24485988]
[56]
Yu Z, Lowndes J, Rippe J. High-fructose corn syrup and sucrose have equivalent effects on energy-regulating hormones at normal human consumption levels. Nutr Res 2013; 33(12): 1043-52.
[PMID: 24267044]
[PMID: 24267044]
[57]
Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab 2013; 2013: 682673.
[http://dx.doi.org/10.1155/2013/682673] [PMID: 23762544]
[http://dx.doi.org/10.1155/2013/682673] [PMID: 23762544]
[58]
Donato J Jr. The central nervous system as a promising target to treat diabetes mellitus. Curr Top Med Chem 2012; 12(19): 2070-81.
[PMID: 23167796]
[PMID: 23167796]
[59]
Steinert RE, Frey F, Töpfer A, Drewe J, Beglinger C. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr 2011; 105(9): 1320-8.
[PMID: 21255472]
[PMID: 21255472]
[60]
Kuhre RE, Gribble FM, Hartmann B, et al. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans. Am J Physiol Gastrointest Liver Physiol 2014; 306(7): G622-30.
[PMID: 24525020]
[PMID: 24525020]
[61]
Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes 2002; 51(3): 606-14.
[PMID: 11872657]
[PMID: 11872657]
[62]
Geyikli1 I, Keskin M, Kör M, Akan M. Increased resistin serum concentrations in patients with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2013; 5(3): 189-93.
[PMID: 24072088]
[PMID: 24072088]
[63]
Little TJ, Gupta N, Case RM, Thompson DG, McLaughlin JT. Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans. Am J Physiol Regul Integr Comp Physiol 2009; 297(3): R632-9.
[PMID: 19535679]
[PMID: 19535679]
[64]
Monsivais P, Perrigue MM, Drewnowski A. Sugars and satiety: Does the type of sweetener make a difference? Am J Clin Nutr 2007; 86(1): 116-23.
[PMID: 17616770]
[PMID: 17616770]
[65]
Akhavan T, Anderson GH. Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men. Am J Clin Nutr 2007; 86(5): 1354-63.
[PMID: 17991646]
[PMID: 17991646]
[66]
Tappy L, Mittendorfer B. Fructose toxicity: Is the science ready for public health actions? Curr Opin Clin Nutr Metab Care 2012; 15(4): 357-61.
[PMID: 22617566]
[PMID: 22617566]
[67]
White JS. Challenging the fructose hypothesis: New perspectives on fructose consumption and metabolism. Adv Nutr 2013; 4(2): 246-56.
[PMID: 23493541]
[PMID: 23493541]
[68]
Ngo Sock ET, Lê KA, Ith M, Kreis R, Boesch C, Tappy L. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr 2010; 103(7): 939-43.
[PMID: 19930762]
[PMID: 19930762]
[69]
Abraha A, Humphreys SM, Clark ML, Matthews DR, Frayn KN. Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br J Nutr 1998; 80(2): 169-75.
[PMID: 9828758]
[PMID: 9828758]
[70]
Wellek S, Blettner M. On the proper use of the crossover design in clinical trials: Part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int 2012; 109(15): 276-81.
[PMID: 22567063]
[PMID: 22567063]
Article Metrics
11
1